| Susceptibility to exacerbation in COPD JR Hurst, A Anzueto, J Vestbo The Lancet Respiratory Medicine 5 (9), e29, 2017 | 3690 | 2017 |
| Characterisation of COPD heterogeneity in the ECLIPSE cohort A Agusti, PMA Calverley, B Celli, HO Coxson, LD Edwards, DA Lomas, ... Respiratory research 11, 1-14, 2010 | 1642 | 2010 |
| Changes in forced expiratory volume in 1 second over time in COPD J Vestbo, LD Edwards, PD Scanlon, JC Yates, A Agusti, P Bakke, ... New England Journal of Medicine 365 (13), 1184-1192, 2011 | 1168 | 2011 |
| Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype A Agustí, LD Edwards, SI Rennard, W MacNee, R Tal-Singer, BE Miller, ... PloS one 7 (5), e37483, 2012 | 1028 | 2012 |
| Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE) J Vestbo, W Anderson, HO Coxson, C Crim, F Dawber, L Edwards, ... European Respiratory Journal 31 (4), 869-873, 2008 | 839 | 2008 |
| Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort J Miller, LD Edwards, A Agustí, P Bakke, PMA Calverley, B Celli, ... Respiratory medicine 107 (9), 1376-1384, 2013 | 569 | 2013 |
| Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease BR Celli, N Locantore, J Yates, R Tal-Singer, BE Miller, P Bakke, ... American journal of respiratory and critical care medicine 185 (10), 1065-1072, 2012 | 540 | 2012 |
| Eosinophilic inflammation in COPD: prevalence and clinical characteristics D Singh, U Kolsum, CE Brightling, N Locantore, A Agusti, R Tal-Singer European Respiratory Journal 44 (6), 1697-1700, 2014 | 533 | 2014 |
| Variants in FAM13A are associated with chronic obstructive pulmonary disease MH Cho, N Boutaoui, BJ Klanderman, JS Sylvia, JP Ziniti, CP Hersh, ... Nature genetics 42 (3), 200-202, 2010 | 474 | 2010 |
| Identification and initial characterization of four novel members of the interleukin-1 family S Kumar, PC McDonnell, R Lehr, L Tierney, MN Tzimas, DE Griswold, ... Journal of Biological Chemistry 275 (14), 10308-10314, 2000 | 469 | 2000 |
| Lung microbiome dynamics in COPD exacerbations Z Wang, M Bafadhel, K Haldar, A Spivak, D Mayhew, BE Miller, ... European Respiratory Journal 47 (4), 1082-1092, 2016 | 431 | 2016 |
| New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries N Shrine, AL Guyatt, AM Erzurumluoglu, VE Jackson, BD Hobbs, ... Nature genetics 51 (3), 481-493, 2019 | 420 | 2019 |
| Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort H Müllerova, DJ Maselli, N Locantore, J Vestbo, JR Hurst, JA Wedzicha, ... Chest 147 (4), 999-1007, 2015 | 411 | 2015 |
| Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization MI Polkey, MA Spruit, LD Edwards, ML Watkins, V Pinto-Plata, J Vestbo, ... American journal of respiratory and critical care medicine 187 (4), 382-386, 2013 | 388 | 2013 |
| Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis BD Hobbs, K De Jong, M Lamontagne, Y Bossé, N Shrine, MS Artigas, ... Nature genetics 49 (3), 426-432, 2017 | 382 | 2017 |
| Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis MH Cho, MLN McDonald, X Zhou, M Mattheisen, PJ Castaldi, CP Hersh, ... The lancet Respiratory medicine 2 (3), 214-225, 2014 | 382 | 2014 |
| Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD DA Lomas, EK Silverman, LD Edwards, NW Locantore, BE Miller, ... European respiratory journal 34 (1), 95-102, 2009 | 319 | 2009 |
| Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations P Sakornsakolpat, D Prokopenko, M Lamontagne, NF Reeve, AL Guyatt, ... Nature genetics 51 (3), 494-505, 2019 | 312 | 2019 |
| Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease A Duvoix, J Dickens, I Haq, D Mannino, B Miller, R Tal-Singer, DA Lomas Thorax 68 (7), 670-676, 2013 | 281 | 2013 |
| The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study HO Coxson, A Dirksen, LD Edwards, JC Yates, A Agusti, P Bakke, ... The lancet Respiratory medicine 1 (2), 129-136, 2013 | 278 | 2013 |
Jørgen VestboThe University of ManchesterVerified email at manchester.ac.uk
